1. Home
  2. RGNX vs CPS Comparison

RGNX vs CPS Comparison

Compare RGNX & CPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • CPS
  • Stock Information
  • Founded
  • RGNX 2008
  • CPS 1960
  • Country
  • RGNX United States
  • CPS United States
  • Employees
  • RGNX N/A
  • CPS N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • CPS Auto Parts:O.E.M.
  • Sector
  • RGNX Health Care
  • CPS Consumer Discretionary
  • Exchange
  • RGNX Nasdaq
  • CPS Nasdaq
  • Market Cap
  • RGNX 451.1M
  • CPS 462.2M
  • IPO Year
  • RGNX 2015
  • CPS N/A
  • Fundamental
  • Price
  • RGNX $12.50
  • CPS $32.64
  • Analyst Decision
  • RGNX Strong Buy
  • CPS Hold
  • Analyst Count
  • RGNX 8
  • CPS 1
  • Target Price
  • RGNX $28.50
  • CPS $12.00
  • AVG Volume (30 Days)
  • RGNX 525.7K
  • CPS 160.1K
  • Earning Date
  • RGNX 11-05-2025
  • CPS 10-30-2025
  • Dividend Yield
  • RGNX N/A
  • CPS N/A
  • EPS Growth
  • RGNX N/A
  • CPS N/A
  • EPS
  • RGNX N/A
  • CPS 1.65
  • Revenue
  • RGNX $155,782,000.00
  • CPS $2,719,148,000.00
  • Revenue This Year
  • RGNX $203.79
  • CPS $2.31
  • Revenue Next Year
  • RGNX $0.72
  • CPS $3.69
  • P/E Ratio
  • RGNX N/A
  • CPS $20.17
  • Revenue Growth
  • RGNX 74.95
  • CPS N/A
  • 52 Week Low
  • RGNX $5.04
  • CPS $10.38
  • 52 Week High
  • RGNX $12.28
  • CPS $40.67
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 76.74
  • CPS 36.14
  • Support Level
  • RGNX $10.24
  • CPS $33.14
  • Resistance Level
  • RGNX $11.00
  • CPS $37.36
  • Average True Range (ATR)
  • RGNX 0.63
  • CPS 1.49
  • MACD
  • RGNX 0.28
  • CPS -0.89
  • Stochastic Oscillator
  • RGNX 93.57
  • CPS 4.10

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About CPS Cooper-Standard Holdings Inc.

Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.

Share on Social Networks: